To further investigate whether the in vivo anti-tumor effect of compound 12 is associated with its inhibition of pro-tumoral macrophages and consequent activation of anti-tumor CD8+ T cells, we analyzed the infiltration of macrophages and CD8+ T cells in the tumor tissue of the Hepa1-6 model. The gene discussed is CD8A; the disease is neoplasm.